Advertisement

Topics

Latest Dermatology NewsRSS

13:25 EST 23rd January 2019 | BioPortfolio

Artificial Skin Could Provide Superhuman Perception

NewsA new type of sensor could lead to artificial skin that someday helps burn victims “feel” and safeguards the rest of us, researchers suggest.

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Psoriasis,Arthritis, Psoriatic,Crohn Disease, Date of authorisation: 15/01/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Psoriasis,Arthritis, Psoriatic,Crohn Disease, Date of authorisation: 15/01/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 23/03/2015, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 23/03/2015, Revision: 10, Status: Authorised

. @ucl geneticists studying diverse Latin American populations identify new genetic variations associated with skin color: http://ow.ly/HuM130norHc 

. @ucl geneticists studying diverse Latin American populations identify new genetic variations associated with skin color: http://ow.ly/HuM130norHc 

Nestlé Skin Health Opens Office in Malaysia

Asia Pacific footprint consolidated through new affiliate in Kuala Lumpur Nestlé Skin Health, a global leader focused on enhancing quality of life by delivering science-based solutions for skin health, today announced the opening of a new office in Malaysia, which will help the company to accelerate growth in the region. The Malaysia affiliat...

Skin Color Evolution Painted in New Light: http://ow.ly/HuM130norHc pic.twitter.com/CKvLKkDaHN

Skin Color Evolution Painted in New Light: http://ow.ly/HuM130norHc  pic.twitter.com/CKvLKkDaHN

Skin Color Evolution Painted in New Light

In our racially charged, and often divided society, skin color is still one of the most definable variations in the human species. While many narrow-minded orators (and even a prominent scientist) would have people believe that the color of their skin suggests they are somehow superior and that their epidermal shade came about through an […] The post Skin Color Evolution Painted in New Light...

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 22/03/2017, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 22/03/2017, Revision: 4, Status: Authorised

January 18 Research Roundup: Skin Cancer, Turning Cancer Cells Into Fat Cells, and a Longevity Test

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Pulse Biosciences Announces Two Appointments Focused on CellFX™ Commercialization: Promotion of Edward Ebbers and Addition of Robert Tyson

− Ebbers named Executive Vice President and General Manager, Dermatology − Tyson named Vice President, Sales North America Pulse Biosciences, Inc. (NASDAQ:PLSE), a medical technology company bringing to market its proprietary CellFX™ System, today announced the promotion of Edward Ebbers to Executive Vice President and Gen...

New PET tracer may improve melanoma detection

A novel radiotracer tested for the first time in humans may help improve the detection of primary and metastatic melanoma, a highly aggressive form of skin cancer, according to a study published in the January issue of the Journal of Nuclear Medicine.

CoverGirl launches Outlast Nudes collection

The Outlast Nudes collection, whic

Tattoos May be Cool, but Could Prove Hazardous to Skin and General Health

Allergist Dr. David Erstein with Advanced Dermatology PC offers tips for proper care of tattoo to minimize risks. ALBERTSON, N.Y. (PRWEB) January 17, 2019 Tattoos may seem cool but turning skin into a canvas for artwork, messages and permanent cosmetic designs poses health risks, some of which can prove serious. That’s the word of caution from David Erstein MD, of New York- and New Jersey-based...

Sylveco's 2019 US Expansion Showcases Innovative Natural Skincare Line

Sylveco, natural beauty brand based in Poland is expanding its US presence for 2019 with its wide range of natural skincare products. The wider outreach throughout the United States is headlined by Sylveco’s signature product Birch Cream, renowned for the rich moisturizing and soothing properties of its key ingredient Betulin (birch tree extract). Along with its less concentrated Birch Light ver...

In-vivo correlations between skin metabolic oscillations and vasomotion in wild-type mice and in a model of oxidative stress

Researchers ID Common Terminology to Describe Non-Melanoma Skin Cancers

The findings of a systematic review may help standardize reflectance confocal microscopy terminology, which is used to describe non-melanocytic lesions.

SeroVital Advanced looks to fight aging from inside

SeroVital Advanced contains an Evening and Morning Blend

Olansky Dermatology Associates Featured as 2019 Top Patient Rated Atlanta Dermatologist by Find Local Doctors

Olansky Dermatology Associates in Atlanta recently earned Find Local Doctors’ recognition of being a Top Patient-Rated Dermatologist for 2019. The award is strictly based on the number of superior reviews and five-star ratings left by their actual patients online. ATLANTA (PRWEB) January 16, 2019 Olansky Dermatology Associates is a well-respected and established dermatology practice in Atlanta ...

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

This study aimed to assess the minimal clinically important differences (MCIDs) for the modified Rodnan skin score (mRSS) using combined data from the Scleroderma Lung Studies (I and II).

Why is Medicaid reimbursement below sustainability?

Recently, a child was on a waitlist for five months to get into my practice. For this article, I will call him Tiny Tim. Tiny Tim, now five years old, has a skin condition known as eczema or atopic dermatitis. When we first met, virtuously every area of his body was covered with wounds from […] Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. ...

Human medicines European public assessment report (EPAR): Remsima, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 10/09/2013, Revision: 14, Status: Authori

Human medicines European public assessment report (EPAR): Remsima, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 10/09/2013, Revision: 14, Status: Authorised

Southeast Asia Atopic Dermatitis Therapeutics Markets 2018-2024 – Growth Driven by Rising Awareness and Expected Launch of Novel Therapies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 – Growth Driven by Rising Awareness and Expected Launch of Novel Therapies” report has been added to ResearchAndMarkets.com’s offering. The Southeast Asia AD market will be valued at $848.6m … Continue reading →

T Cell Specific Surface Glycoprotein CD28 TP44 or CD28 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

T Cell Specific Surface Glycoprotein CD28 TP44 or CD28 Pipeline Review, H2 2018SummaryT Cell Specific Surface Glycoprotein CD28 TP44 or CD28 CD28 is a proteins expressed on T cells. It costimulates signals required for T cell activation and survival. It enhances the production of IL4 and IL10 in Tcells in conjunction with TCR/CD3 ligation and CD40L costimulation. T Cell Specific Surface Glycopro...

Hope for New Apoptotic Regulatory Pathway in Treating Non-Melanoma Skin Cancers

Researchers studied whether the mechanistic target of mTORC2 directs UVB–induced apoptosis by regulating the expression of NOXA downstream of FOXO3a.

European Commission Approves Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) for First-Line Treatment of Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma

First I-O/I-O combination regimen to receive European approval for previously untreated patients with advanced renal cell carcinoma Approval based on results from Phase 3 CheckMate -214 trial Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission has approved the combination of Opdivo (nivolumab) 3 mg/kg p...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Dermatology market research data and corporate reports here